nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—Bromfenac—Balsalazide—Crohn's disease	0.125	0.519	CrCrCtD
Indomethacin—CXCL8—Crohn's disease	0.118	0.644	CbGaD
Indomethacin—Bezafibrate—Balsalazide—Crohn's disease	0.116	0.481	CrCrCtD
Indomethacin—migraine—Prednisone—Crohn's disease	0.114	0.508	CpDpCtD
Indomethacin—osteoarthritis—Prednisone—Crohn's disease	0.111	0.492	CpDpCtD
Indomethacin—PPARG—Balsalazide—Crohn's disease	0.0573	0.222	CbGbCtD
Indomethacin—PPARG—Mesalazine—Crohn's disease	0.0458	0.178	CbGbCtD
Indomethacin—PTGS2—Crohn's disease	0.0343	0.188	CbGaD
Indomethacin—ALB—Crohn's disease	0.0306	0.167	CbGaD
Indomethacin—PPARG—Sulfasalazine—Crohn's disease	0.0256	0.0993	CbGbCtD
Indomethacin—PTGS2—Balsalazide—Crohn's disease	0.0171	0.0663	CbGbCtD
Indomethacin—ABCC4—Mercaptopurine—Crohn's disease	0.0159	0.0618	CbGbCtD
Indomethacin—PTGS1—Balsalazide—Crohn's disease	0.0144	0.056	CbGbCtD
Indomethacin—PTGS2—Mesalazine—Crohn's disease	0.0137	0.053	CbGbCtD
Indomethacin—PTGS1—Mesalazine—Crohn's disease	0.0115	0.0448	CbGbCtD
Indomethacin—SLC22A8—Mercaptopurine—Crohn's disease	0.00995	0.0386	CbGbCtD
Indomethacin—SLCO1B1—Sulfasalazine—Crohn's disease	0.00879	0.0341	CbGbCtD
Indomethacin—ABCC2—Sulfasalazine—Crohn's disease	0.00772	0.03	CbGbCtD
Indomethacin—PTGS2—Sulfasalazine—Crohn's disease	0.00763	0.0296	CbGbCtD
Indomethacin—SLCO1A2—Prednisone—Crohn's disease	0.00745	0.0289	CbGbCtD
Indomethacin—PTGS1—Sulfasalazine—Crohn's disease	0.00645	0.025	CbGbCtD
Indomethacin—ALB—Prednisone—Crohn's disease	0.00385	0.0149	CbGbCtD
Indomethacin—SLC10A1—bile—Crohn's disease	0.00278	0.125	CbGeAlD
Indomethacin—Intestinal ulcer—Mercaptopurine—Crohn's disease	0.00268	0.0794	CcSEcCtD
Indomethacin—CYP2C19—Prednisone—Crohn's disease	0.00249	0.00968	CbGbCtD
Indomethacin—ABCB1—Prednisone—Crohn's disease	0.00201	0.00781	CbGbCtD
Indomethacin—Hepatitis toxic—Azathioprine—Crohn's disease	0.00141	0.0418	CcSEcCtD
Indomethacin—ABCC2—bile—Crohn's disease	0.0014	0.0626	CbGeAlD
Indomethacin—Hepatitis toxic—Mesalazine—Crohn's disease	0.00129	0.0381	CcSEcCtD
Indomethacin—Crohn's disease—Mesalazine—Crohn's disease	0.00122	0.0361	CcSEcCtD
Indomethacin—PLA2G2A—mouth—Crohn's disease	0.000763	0.0342	CbGeAlD
Indomethacin—Nephritis—Mesalazine—Crohn's disease	0.000619	0.0183	CcSEcCtD
Indomethacin—CES1—gall bladder—Crohn's disease	0.000594	0.0267	CbGeAlD
Indomethacin—Bone marrow depression—Mercaptopurine—Crohn's disease	0.000577	0.0171	CcSEcCtD
Indomethacin—Rectal tenesmus—Mesalazine—Crohn's disease	0.000567	0.0168	CcSEcCtD
Indomethacin—Alkalosis—Prednisone—Crohn's disease	0.000557	0.0165	CcSEcCtD
Indomethacin—PPARG—Methyldopa—Mesalazine—Crohn's disease	0.00054	1	CbGdCrCtD
Indomethacin—Erythema nodosum—Mesalazine—Crohn's disease	0.000489	0.0145	CcSEcCtD
Indomethacin—ABCC3—gall bladder—Crohn's disease	0.000485	0.0218	CbGeAlD
Indomethacin—GLO1—epithelium—Crohn's disease	0.000477	0.0214	CbGeAlD
Indomethacin—Distention—Prednisone—Crohn's disease	0.000474	0.014	CcSEcCtD
Indomethacin—Tolmetin—CXCL8—Crohn's disease	0.000462	0.343	CrCbGaD
Indomethacin—GLO1—smooth muscle tissue—Crohn's disease	0.00046	0.0206	CbGeAlD
Indomethacin—GLO1—skin of body—Crohn's disease	0.000454	0.0204	CbGeAlD
Indomethacin—Proctalgia—Mesalazine—Crohn's disease	0.000451	0.0133	CcSEcCtD
Indomethacin—Abdominal bloating—Mesalazine—Crohn's disease	0.000444	0.0131	CcSEcCtD
Indomethacin—PLA2G2A—epithelium—Crohn's disease	0.000444	0.0199	CbGeAlD
Indomethacin—Nephrotic syndrome—Mesalazine—Crohn's disease	0.000437	0.0129	CcSEcCtD
Indomethacin—PLA2G2A—smooth muscle tissue—Crohn's disease	0.000428	0.0192	CbGeAlD
Indomethacin—CXCL8—smooth muscle tissue—Crohn's disease	0.000423	0.019	CbGeAlD
Indomethacin—PPARA—epithelium—Crohn's disease	0.000414	0.0186	CbGeAlD
Indomethacin—GLO1—mammalian vulva—Crohn's disease	0.000414	0.0186	CbGeAlD
Indomethacin—ALB—gall bladder—Crohn's disease	0.000413	0.0186	CbGeAlD
Indomethacin—Ulcer—Mercaptopurine—Crohn's disease	0.000412	0.0122	CcSEcCtD
Indomethacin—PPARA—smooth muscle tissue—Crohn's disease	0.000399	0.0179	CbGeAlD
Indomethacin—PPARA—skin of body—Crohn's disease	0.000394	0.0177	CbGeAlD
Indomethacin—Anorectal discomfort—Mesalazine—Crohn's disease	0.000387	0.0114	CcSEcCtD
Indomethacin—PLA2G2A—mammalian vulva—Crohn's disease	0.000385	0.0173	CbGeAlD
Indomethacin—Blood potassium increased—Prednisone—Crohn's disease	0.00037	0.011	CcSEcCtD
Indomethacin—GLO1—lymphoid tissue—Crohn's disease	0.000368	0.0165	CbGeAlD
Indomethacin—GLO1—digestive system—Crohn's disease	0.000363	0.0163	CbGeAlD
Indomethacin—Tolmetin—MPO—Crohn's disease	0.00036	0.267	CrCbGaD
Indomethacin—Platelet count decreased—Mesalazine—Crohn's disease	0.000355	0.0105	CcSEcCtD
Indomethacin—UGT1A9—digestive system—Crohn's disease	0.000352	0.0158	CbGeAlD
Indomethacin—Mouth ulceration—Mercaptopurine—Crohn's disease	0.000352	0.0104	CcSEcCtD
Indomethacin—Bone marrow depression—Azathioprine—Crohn's disease	0.000344	0.0102	CcSEcCtD
Indomethacin—PLA2G2A—lymphoid tissue—Crohn's disease	0.000342	0.0153	CbGeAlD
Indomethacin—PLA2G2A—digestive system—Crohn's disease	0.000338	0.0152	CbGeAlD
Indomethacin—PTGR2—lymph node—Crohn's disease	0.000336	0.0151	CbGeAlD
Indomethacin—AKR1C3—smooth muscle tissue—Crohn's disease	0.000332	0.0149	CbGeAlD
Indomethacin—PPARA—lymphoid tissue—Crohn's disease	0.000319	0.0143	CbGeAlD
Indomethacin—PPARA—digestive system—Crohn's disease	0.000315	0.0142	CbGeAlD
Indomethacin—Nephritis interstitial—Mesalazine—Crohn's disease	0.000313	0.00926	CcSEcCtD
Indomethacin—Bone marrow depression—Mesalazine—Crohn's disease	0.000313	0.00926	CcSEcCtD
Indomethacin—SLC10A1—digestive system—Crohn's disease	0.000303	0.0136	CbGeAlD
Indomethacin—AKR1C3—mammalian vulva—Crohn's disease	0.000299	0.0134	CbGeAlD
Indomethacin—Epilepsy—Prednisone—Crohn's disease	0.000294	0.0087	CcSEcCtD
Indomethacin—UGT2B7—digestive system—Crohn's disease	0.000284	0.0128	CbGeAlD
Indomethacin—SLC22A11—digestive system—Crohn's disease	0.000277	0.0124	CbGeAlD
Indomethacin—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.000276	0.00817	CcSEcCtD
Indomethacin—Neoplasm malignant—Azathioprine—Crohn's disease	0.000272	0.00804	CcSEcCtD
Indomethacin—SLC22A7—digestive system—Crohn's disease	0.00027	0.0121	CbGeAlD
Indomethacin—Tenderness—Mesalazine—Crohn's disease	0.000242	0.00717	CcSEcCtD
Indomethacin—UGT1A1—digestive system—Crohn's disease	0.000242	0.0108	CbGeAlD
Indomethacin—Proteinuria—Mesalazine—Crohn's disease	0.00024	0.00712	CcSEcCtD
Indomethacin—Vasculitis—Azathioprine—Crohn's disease	0.000238	0.00703	CcSEcCtD
Indomethacin—Protein urine present—Mesalazine—Crohn's disease	0.000237	0.00702	CcSEcCtD
Indomethacin—CES1—lymphoid tissue—Crohn's disease	0.000237	0.0106	CbGeAlD
Indomethacin—CES1—digestive system—Crohn's disease	0.000234	0.0105	CbGeAlD
Indomethacin—Rectal haemorrhage—Mesalazine—Crohn's disease	0.000234	0.00692	CcSEcCtD
Indomethacin—Pancytopenia—Mercaptopurine—Crohn's disease	0.000232	0.00686	CcSEcCtD
Indomethacin—PPARG—epithelium—Crohn's disease	0.000228	0.0102	CbGeAlD
Indomethacin—Gout—Mesalazine—Crohn's disease	0.000226	0.0067	CcSEcCtD
Indomethacin—PTGS2—gall bladder—Crohn's disease	0.000225	0.0101	CbGeAlD
Indomethacin—Colitis—Azathioprine—Crohn's disease	0.000223	0.00659	CcSEcCtD
Indomethacin—PPARG—smooth muscle tissue—Crohn's disease	0.00022	0.00986	CbGeAlD
Indomethacin—Aplastic anaemia—Azathioprine—Crohn's disease	0.000218	0.00645	CcSEcCtD
Indomethacin—PPARG—skin of body—Crohn's disease	0.000217	0.00973	CbGeAlD
Indomethacin—Stomatitis—Mercaptopurine—Crohn's disease	0.000212	0.00628	CcSEcCtD
Indomethacin—GLO1—lymph node—Crohn's disease	0.000207	0.00931	CbGeAlD
Indomethacin—Colitis—Mesalazine—Crohn's disease	0.000203	0.006	CcSEcCtD
Indomethacin—Skin exfoliation—Mesalazine—Crohn's disease	0.000202	0.00597	CcSEcCtD
Indomethacin—SLCO1B1—digestive system—Crohn's disease	0.000201	0.00903	CbGeAlD
Indomethacin—Bromfenac—PTGS2—Crohn's disease	0.000201	0.149	CrCbGaD
Indomethacin—PTGS2—mouth—Crohn's disease	0.0002	0.00899	CbGeAlD
Indomethacin—Aplastic anaemia—Mesalazine—Crohn's disease	0.000198	0.00587	CcSEcCtD
Indomethacin—PPARG—mammalian vulva—Crohn's disease	0.000198	0.00888	CbGeAlD
Indomethacin—Coma—Mesalazine—Crohn's disease	0.000193	0.00571	CcSEcCtD
Indomethacin—PLA2G2A—lymph node—Crohn's disease	0.000193	0.00866	CbGeAlD
Indomethacin—Ecchymosis—Mesalazine—Crohn's disease	0.000191	0.00565	CcSEcCtD
Indomethacin—Mouth ulceration—Mesalazine—Crohn's disease	0.000191	0.00565	CcSEcCtD
Indomethacin—CXCL8—lymph node—Crohn's disease	0.000191	0.00857	CbGeAlD
Indomethacin—ABCC3—digestive system—Crohn's disease	0.000191	0.00856	CbGeAlD
Indomethacin—PPARA—lymph node—Crohn's disease	0.00018	0.00809	CbGeAlD
Indomethacin—PPARG—lymphoid tissue—Crohn's disease	0.000176	0.00788	CbGeAlD
Indomethacin—PPARG—digestive system—Crohn's disease	0.000173	0.00778	CbGeAlD
Indomethacin—Gastroenteritis—Mesalazine—Crohn's disease	0.000173	0.00512	CcSEcCtD
Indomethacin—Alopecia—Mercaptopurine—Crohn's disease	0.000173	0.00511	CcSEcCtD
Indomethacin—Deafness—Mesalazine—Crohn's disease	0.000171	0.00507	CcSEcCtD
Indomethacin—Eye pain—Mesalazine—Crohn's disease	0.00017	0.00503	CcSEcCtD
Indomethacin—Peptic ulcer—Prednisone—Crohn's disease	0.000167	0.00495	CcSEcCtD
Indomethacin—SLCO1A2—digestive system—Crohn's disease	0.000164	0.00734	CbGeAlD
Indomethacin—Renal impairment—Mesalazine—Crohn's disease	0.000161	0.00477	CcSEcCtD
Indomethacin—ABCC4—digestive system—Crohn's disease	0.000157	0.00707	CbGeAlD
Indomethacin—Anaemia—Mercaptopurine—Crohn's disease	0.000157	0.00466	CcSEcCtD
Indomethacin—Osteoarthritis—Mesalazine—Crohn's disease	0.000153	0.00454	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000153	0.00454	CcSEcCtD
Indomethacin—ABCC1—mammalian vulva—Crohn's disease	0.000153	0.00687	CbGeAlD
Indomethacin—ABCC2—digestive system—Crohn's disease	0.000152	0.00684	CbGeAlD
Indomethacin—Leukopenia—Mercaptopurine—Crohn's disease	0.000152	0.00451	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000152	0.00449	CcSEcCtD
Indomethacin—AKR1C3—lymph node—Crohn's disease	0.00015	0.00672	CbGeAlD
Indomethacin—Abdominal pain upper—Mesalazine—Crohn's disease	0.00014	0.00415	CcSEcCtD
Indomethacin—Abdominal discomfort—Azathioprine—Crohn's disease	0.00014	0.00413	CcSEcCtD
Indomethacin—Oedema—Mercaptopurine—Crohn's disease	0.000139	0.00411	CcSEcCtD
Indomethacin—Pancytopenia—Azathioprine—Crohn's disease	0.000138	0.00409	CcSEcCtD
Indomethacin—Glycosuria—Prednisone—Crohn's disease	0.000138	0.00408	CcSEcCtD
Indomethacin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000136	0.00402	CcSEcCtD
Indomethacin—Petechiae—Prednisone—Crohn's disease	0.000136	0.00402	CcSEcCtD
Indomethacin—Gastritis—Mesalazine—Crohn's disease	0.000136	0.00402	CcSEcCtD
Indomethacin—Tolmetin—PTGS2—Crohn's disease	0.000135	0.0999	CrCbGaD
Indomethacin—CES1—lymph node—Crohn's disease	0.000134	0.006	CbGeAlD
Indomethacin—Abdominal distension—Mesalazine—Crohn's disease	0.000133	0.00395	CcSEcCtD
Indomethacin—Asthma—Mesalazine—Crohn's disease	0.000133	0.00392	CcSEcCtD
Indomethacin—Anorexia—Mercaptopurine—Crohn's disease	0.000132	0.00392	CcSEcCtD
Indomethacin—CYP2C19—digestive system—Crohn's disease	0.000131	0.00588	CbGeAlD
Indomethacin—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000129	0.00381	CcSEcCtD
Indomethacin—Abdominal discomfort—Mesalazine—Crohn's disease	0.000127	0.00376	CcSEcCtD
Indomethacin—Pancytopenia—Mesalazine—Crohn's disease	0.000126	0.00373	CcSEcCtD
Indomethacin—Pollakiuria—Mesalazine—Crohn's disease	0.000122	0.00362	CcSEcCtD
Indomethacin—PTGS1—epithelium—Crohn's disease	0.000122	0.00547	CbGeAlD
Indomethacin—Agranulocytosis—Azathioprine—Crohn's disease	0.000121	0.00358	CcSEcCtD
Indomethacin—Decreased appetite—Mercaptopurine—Crohn's disease	0.000121	0.00357	CcSEcCtD
Indomethacin—Weight increased—Mesalazine—Crohn's disease	0.000121	0.00357	CcSEcCtD
Indomethacin—Ulcer—Prednisone—Crohn's disease	0.000118	0.0035	CcSEcCtD
Indomethacin—Depression—Mesalazine—Crohn's disease	0.000118	0.00349	CcSEcCtD
Indomethacin—PTGS1—smooth muscle tissue—Crohn's disease	0.000117	0.00527	CbGeAlD
Indomethacin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000117	0.00347	CcSEcCtD
Indomethacin—Haemoglobin—Azathioprine—Crohn's disease	0.000117	0.00346	CcSEcCtD
Indomethacin—Haemorrhage—Azathioprine—Crohn's disease	0.000116	0.00345	CcSEcCtD
Indomethacin—PTGS2—epithelium—Crohn's disease	0.000116	0.00523	CbGeAlD
Indomethacin—Renal failure—Mesalazine—Crohn's disease	0.000116	0.00344	CcSEcCtD
Indomethacin—PTGS1—skin of body—Crohn's disease	0.000116	0.0052	CbGeAlD
Indomethacin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000116	0.00343	CcSEcCtD
Indomethacin—Stomatitis—Mesalazine—Crohn's disease	0.000115	0.00341	CcSEcCtD
Indomethacin—Jaundice—Mesalazine—Crohn's disease	0.000115	0.00341	CcSEcCtD
Indomethacin—Vasculitis—Prednisone—Crohn's disease	0.000115	0.00339	CcSEcCtD
Indomethacin—Sweating—Mesalazine—Crohn's disease	0.000113	0.00335	CcSEcCtD
Indomethacin—Haematuria—Mesalazine—Crohn's disease	0.000113	0.00334	CcSEcCtD
Indomethacin—PTGS2—smooth muscle tissue—Crohn's disease	0.000112	0.00504	CbGeAlD
Indomethacin—Epistaxis—Mesalazine—Crohn's disease	0.000111	0.0033	CcSEcCtD
Indomethacin—PTGS2—skin of body—Crohn's disease	0.000111	0.00497	CbGeAlD
Indomethacin—Agranulocytosis—Mesalazine—Crohn's disease	0.00011	0.00326	CcSEcCtD
Indomethacin—Erythema multiforme—Azathioprine—Crohn's disease	0.00011	0.00326	CcSEcCtD
Indomethacin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00011	0.00325	CcSEcCtD
Indomethacin—ABCC3—lymph node—Crohn's disease	0.000109	0.00489	CbGeAlD
Indomethacin—Skin exfoliation—Prednisone—Crohn's disease	0.000107	0.00316	CcSEcCtD
Indomethacin—Haemoglobin—Mesalazine—Crohn's disease	0.000107	0.00316	CcSEcCtD
Indomethacin—Fluid retention—Prednisone—Crohn's disease	0.000106	0.00314	CcSEcCtD
Indomethacin—Hepatitis—Mesalazine—Crohn's disease	0.000106	0.00314	CcSEcCtD
Indomethacin—Haemorrhage—Mesalazine—Crohn's disease	0.000106	0.00314	CcSEcCtD
Indomethacin—PTGS1—mammalian vulva—Crohn's disease	0.000106	0.00474	CbGeAlD
Indomethacin—Arrhythmia—Azathioprine—Crohn's disease	0.000104	0.00308	CcSEcCtD
Indomethacin—Alopecia—Azathioprine—Crohn's disease	0.000103	0.00305	CcSEcCtD
Indomethacin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000102	0.00303	CcSEcCtD
Indomethacin—CYP2C9—digestive system—Crohn's disease	0.000102	0.00456	CbGeAlD
Indomethacin—Naproxen—PTGS2—Crohn's disease	0.000101	0.0752	CrCbGaD
Indomethacin—Ecchymosis—Prednisone—Crohn's disease	0.000101	0.00299	CcSEcCtD
Indomethacin—Erythema multiforme—Mesalazine—Crohn's disease	0.0001	0.00297	CcSEcCtD
Indomethacin—Pulmonary oedema—Prednisone—Crohn's disease	9.95e-05	0.00294	CcSEcCtD
Indomethacin—PPARG—lymph node—Crohn's disease	9.9e-05	0.00445	CbGeAlD
Indomethacin—Tinnitus—Mesalazine—Crohn's disease	9.89e-05	0.00293	CcSEcCtD
Indomethacin—Diarrhoea—Mercaptopurine—Crohn's disease	9.5e-05	0.00281	CcSEcCtD
Indomethacin—Ill-defined disorder—Azathioprine—Crohn's disease	9.41e-05	0.00278	CcSEcCtD
Indomethacin—Alopecia—Mesalazine—Crohn's disease	9.38e-05	0.00277	CcSEcCtD
Indomethacin—Thrombophlebitis—Prednisone—Crohn's disease	9.38e-05	0.00277	CcSEcCtD
Indomethacin—Anaemia—Azathioprine—Crohn's disease	9.37e-05	0.00277	CcSEcCtD
Indomethacin—ALB—lymph node—Crohn's disease	9.29e-05	0.00417	CbGeAlD
Indomethacin—PTGS1—digestive system—Crohn's disease	9.27e-05	0.00416	CbGeAlD
Indomethacin—Erythema—Mesalazine—Crohn's disease	9.24e-05	0.00273	CcSEcCtD
Indomethacin—Malaise—Azathioprine—Crohn's disease	9.15e-05	0.00271	CcSEcCtD
Indomethacin—Flatulence—Mesalazine—Crohn's disease	9.1e-05	0.00269	CcSEcCtD
Indomethacin—Leukopenia—Azathioprine—Crohn's disease	9.08e-05	0.00269	CcSEcCtD
Indomethacin—Vascular purpura—Prednisone—Crohn's disease	9.07e-05	0.00268	CcSEcCtD
Indomethacin—Tension—Mesalazine—Crohn's disease	9.06e-05	0.00268	CcSEcCtD
Indomethacin—Naproxen—ALB—Crohn's disease	9.03e-05	0.067	CrCbGaD
Indomethacin—ABCC4—lymph node—Crohn's disease	8.99e-05	0.00404	CbGeAlD
Indomethacin—Nervousness—Mesalazine—Crohn's disease	8.97e-05	0.00265	CcSEcCtD
Indomethacin—PTGS2—lymphoid tissue—Crohn's disease	8.97e-05	0.00403	CbGeAlD
Indomethacin—Cardiac failure congestive—Prednisone—Crohn's disease	8.95e-05	0.00265	CcSEcCtD
Indomethacin—PTGS2—digestive system—Crohn's disease	8.86e-05	0.00398	CbGeAlD
Indomethacin—Vomiting—Mercaptopurine—Crohn's disease	8.83e-05	0.00261	CcSEcCtD
Indomethacin—Rash—Mercaptopurine—Crohn's disease	8.76e-05	0.00259	CcSEcCtD
Indomethacin—Dermatitis—Mercaptopurine—Crohn's disease	8.75e-05	0.00259	CcSEcCtD
Indomethacin—Vision blurred—Mesalazine—Crohn's disease	8.71e-05	0.00258	CcSEcCtD
Indomethacin—ABCC2—lymph node—Crohn's disease	8.7e-05	0.00391	CbGeAlD
Indomethacin—Ill-defined disorder—Mesalazine—Crohn's disease	8.57e-05	0.00254	CcSEcCtD
Indomethacin—Anaemia—Mesalazine—Crohn's disease	8.54e-05	0.00253	CcSEcCtD
Indomethacin—Discomfort—Azathioprine—Crohn's disease	8.53e-05	0.00252	CcSEcCtD
Indomethacin—Angioedema—Mesalazine—Crohn's disease	8.44e-05	0.0025	CcSEcCtD
Indomethacin—Purpura—Prednisone—Crohn's disease	8.42e-05	0.00249	CcSEcCtD
Indomethacin—Malaise—Mesalazine—Crohn's disease	8.33e-05	0.00246	CcSEcCtD
Indomethacin—Vertigo—Mesalazine—Crohn's disease	8.3e-05	0.00246	CcSEcCtD
Indomethacin—Syncope—Mesalazine—Crohn's disease	8.28e-05	0.00245	CcSEcCtD
Indomethacin—Leukopenia—Mesalazine—Crohn's disease	8.27e-05	0.00245	CcSEcCtD
Indomethacin—Nausea—Mercaptopurine—Crohn's disease	8.25e-05	0.00244	CcSEcCtD
Indomethacin—Palpitations—Mesalazine—Crohn's disease	8.16e-05	0.00242	CcSEcCtD
Indomethacin—Loss of consciousness—Mesalazine—Crohn's disease	8.12e-05	0.0024	CcSEcCtD
Indomethacin—Osteoarthritis—Prednisone—Crohn's disease	8.12e-05	0.0024	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	8.12e-05	0.0024	CcSEcCtD
Indomethacin—Thrombocytopenia—Azathioprine—Crohn's disease	8.1e-05	0.0024	CcSEcCtD
Indomethacin—Hypertension—Mesalazine—Crohn's disease	7.98e-05	0.00236	CcSEcCtD
Indomethacin—Psychotic disorder—Prednisone—Crohn's disease	7.93e-05	0.00235	CcSEcCtD
Indomethacin—Chest pain—Mesalazine—Crohn's disease	7.86e-05	0.00233	CcSEcCtD
Indomethacin—Anxiety—Mesalazine—Crohn's disease	7.84e-05	0.00232	CcSEcCtD
Indomethacin—Discomfort—Mesalazine—Crohn's disease	7.77e-05	0.0023	CcSEcCtD
Indomethacin—Hypotension—Azathioprine—Crohn's disease	7.73e-05	0.00229	CcSEcCtD
Indomethacin—ABCC1—lymph node—Crohn's disease	7.67e-05	0.00344	CbGeAlD
Indomethacin—Confusional state—Mesalazine—Crohn's disease	7.6e-05	0.00225	CcSEcCtD
Indomethacin—Oedema—Mesalazine—Crohn's disease	7.54e-05	0.00223	CcSEcCtD
Indomethacin—Anaphylactic shock—Mesalazine—Crohn's disease	7.54e-05	0.00223	CcSEcCtD
Indomethacin—Shock—Mesalazine—Crohn's disease	7.42e-05	0.00219	CcSEcCtD
Indomethacin—Thrombocytopenia—Mesalazine—Crohn's disease	7.38e-05	0.00218	CcSEcCtD
Indomethacin—Tachycardia—Mesalazine—Crohn's disease	7.36e-05	0.00218	CcSEcCtD
Indomethacin—Hyperhidrosis—Mesalazine—Crohn's disease	7.29e-05	0.00216	CcSEcCtD
Indomethacin—ABCB1—epithelium—Crohn's disease	7.2e-05	0.00323	CbGeAlD
Indomethacin—Anorexia—Mesalazine—Crohn's disease	7.19e-05	0.00213	CcSEcCtD
Indomethacin—Muscular weakness—Prednisone—Crohn's disease	7.16e-05	0.00212	CcSEcCtD
Indomethacin—Abdominal distension—Prednisone—Crohn's disease	7.06e-05	0.00209	CcSEcCtD
Indomethacin—Hypotension—Mesalazine—Crohn's disease	7.04e-05	0.00208	CcSEcCtD
Indomethacin—Feeling abnormal—Azathioprine—Crohn's disease	6.82e-05	0.00202	CcSEcCtD
Indomethacin—Insomnia—Mesalazine—Crohn's disease	6.82e-05	0.00202	CcSEcCtD
Indomethacin—Paraesthesia—Mesalazine—Crohn's disease	6.77e-05	0.002	CcSEcCtD
Indomethacin—Gastrointestinal pain—Azathioprine—Crohn's disease	6.77e-05	0.002	CcSEcCtD
Indomethacin—Dyspnoea—Mesalazine—Crohn's disease	6.72e-05	0.00199	CcSEcCtD
Indomethacin—Somnolence—Mesalazine—Crohn's disease	6.7e-05	0.00198	CcSEcCtD
Indomethacin—Dyspepsia—Mesalazine—Crohn's disease	6.64e-05	0.00196	CcSEcCtD
Indomethacin—Decreased appetite—Mesalazine—Crohn's disease	6.55e-05	0.00194	CcSEcCtD
Indomethacin—Abdominal pain—Azathioprine—Crohn's disease	6.54e-05	0.00194	CcSEcCtD
Indomethacin—Body temperature increased—Azathioprine—Crohn's disease	6.54e-05	0.00194	CcSEcCtD
Indomethacin—Fatigue—Mesalazine—Crohn's disease	6.5e-05	0.00192	CcSEcCtD
Indomethacin—Pain—Mesalazine—Crohn's disease	6.45e-05	0.00191	CcSEcCtD
Indomethacin—Constipation—Mesalazine—Crohn's disease	6.45e-05	0.00191	CcSEcCtD
Indomethacin—Weight increased—Prednisone—Crohn's disease	6.38e-05	0.00189	CcSEcCtD
Indomethacin—Hyperglycaemia—Prednisone—Crohn's disease	6.33e-05	0.00187	CcSEcCtD
Indomethacin—ABCB1—mammalian vulva—Crohn's disease	6.25e-05	0.00281	CbGeAlD
Indomethacin—Depression—Prednisone—Crohn's disease	6.24e-05	0.00185	CcSEcCtD
Indomethacin—Feeling abnormal—Mesalazine—Crohn's disease	6.21e-05	0.00184	CcSEcCtD
Indomethacin—Gastrointestinal pain—Mesalazine—Crohn's disease	6.16e-05	0.00182	CcSEcCtD
Indomethacin—Neuropathy peripheral—Prednisone—Crohn's disease	6.13e-05	0.00181	CcSEcCtD
Indomethacin—Hypersensitivity—Azathioprine—Crohn's disease	6.1e-05	0.0018	CcSEcCtD
Indomethacin—Urticaria—Mesalazine—Crohn's disease	5.99e-05	0.00177	CcSEcCtD
Indomethacin—Abdominal pain—Mesalazine—Crohn's disease	5.96e-05	0.00176	CcSEcCtD
Indomethacin—Body temperature increased—Mesalazine—Crohn's disease	5.96e-05	0.00176	CcSEcCtD
Indomethacin—Bradycardia—Prednisone—Crohn's disease	5.72e-05	0.00169	CcSEcCtD
Indomethacin—Diarrhoea—Azathioprine—Crohn's disease	5.66e-05	0.00168	CcSEcCtD
Indomethacin—Haemoglobin—Prednisone—Crohn's disease	5.64e-05	0.00167	CcSEcCtD
Indomethacin—Haemorrhage—Prednisone—Crohn's disease	5.61e-05	0.00166	CcSEcCtD
Indomethacin—Hypersensitivity—Mesalazine—Crohn's disease	5.55e-05	0.00164	CcSEcCtD
Indomethacin—ABCB1—lymphoid tissue—Crohn's disease	5.55e-05	0.00249	CbGeAlD
Indomethacin—ABCB1—digestive system—Crohn's disease	5.48e-05	0.00246	CbGeAlD
Indomethacin—Dizziness—Azathioprine—Crohn's disease	5.47e-05	0.00162	CcSEcCtD
Indomethacin—Asthenia—Mesalazine—Crohn's disease	5.41e-05	0.0016	CcSEcCtD
Indomethacin—Pruritus—Mesalazine—Crohn's disease	5.33e-05	0.00158	CcSEcCtD
Indomethacin—PTGS1—lymph node—Crohn's disease	5.29e-05	0.00238	CbGeAlD
Indomethacin—Vomiting—Azathioprine—Crohn's disease	5.26e-05	0.00156	CcSEcCtD
Indomethacin—Rash—Azathioprine—Crohn's disease	5.22e-05	0.00154	CcSEcCtD
Indomethacin—Dermatitis—Azathioprine—Crohn's disease	5.21e-05	0.00154	CcSEcCtD
Indomethacin—Flushing—Prednisone—Crohn's disease	5.21e-05	0.00154	CcSEcCtD
Indomethacin—Headache—Azathioprine—Crohn's disease	5.19e-05	0.00153	CcSEcCtD
Indomethacin—Diarrhoea—Mesalazine—Crohn's disease	5.16e-05	0.00153	CcSEcCtD
Indomethacin—PTGS2—lymph node—Crohn's disease	5.06e-05	0.00227	CbGeAlD
Indomethacin—Arrhythmia—Prednisone—Crohn's disease	5.02e-05	0.00148	CcSEcCtD
Indomethacin—Dizziness—Mesalazine—Crohn's disease	4.99e-05	0.00148	CcSEcCtD
Indomethacin—Alopecia—Prednisone—Crohn's disease	4.96e-05	0.00147	CcSEcCtD
Indomethacin—Nausea—Azathioprine—Crohn's disease	4.92e-05	0.00145	CcSEcCtD
Indomethacin—Erythema—Prednisone—Crohn's disease	4.89e-05	0.00145	CcSEcCtD
Indomethacin—Vomiting—Mesalazine—Crohn's disease	4.79e-05	0.00142	CcSEcCtD
Indomethacin—Rash—Mesalazine—Crohn's disease	4.75e-05	0.00141	CcSEcCtD
Indomethacin—Dermatitis—Mesalazine—Crohn's disease	4.75e-05	0.00141	CcSEcCtD
Indomethacin—Headache—Mesalazine—Crohn's disease	4.72e-05	0.0014	CcSEcCtD
Indomethacin—Vision blurred—Prednisone—Crohn's disease	4.61e-05	0.00136	CcSEcCtD
Indomethacin—Ill-defined disorder—Prednisone—Crohn's disease	4.53e-05	0.00134	CcSEcCtD
Indomethacin—Anaemia—Prednisone—Crohn's disease	4.52e-05	0.00134	CcSEcCtD
Indomethacin—Nausea—Mesalazine—Crohn's disease	4.48e-05	0.00133	CcSEcCtD
Indomethacin—Angioedema—Prednisone—Crohn's disease	4.47e-05	0.00132	CcSEcCtD
Indomethacin—Malaise—Prednisone—Crohn's disease	4.41e-05	0.0013	CcSEcCtD
Indomethacin—Vertigo—Prednisone—Crohn's disease	4.39e-05	0.0013	CcSEcCtD
Indomethacin—Syncope—Prednisone—Crohn's disease	4.38e-05	0.0013	CcSEcCtD
Indomethacin—Loss of consciousness—Prednisone—Crohn's disease	4.3e-05	0.00127	CcSEcCtD
Indomethacin—Convulsion—Prednisone—Crohn's disease	4.23e-05	0.00125	CcSEcCtD
Indomethacin—Hypertension—Prednisone—Crohn's disease	4.22e-05	0.00125	CcSEcCtD
Indomethacin—Anxiety—Prednisone—Crohn's disease	4.15e-05	0.00123	CcSEcCtD
Indomethacin—Discomfort—Prednisone—Crohn's disease	4.11e-05	0.00122	CcSEcCtD
Indomethacin—Oedema—Prednisone—Crohn's disease	3.99e-05	0.00118	CcSEcCtD
Indomethacin—Anaphylactic shock—Prednisone—Crohn's disease	3.99e-05	0.00118	CcSEcCtD
Indomethacin—Shock—Prednisone—Crohn's disease	3.92e-05	0.00116	CcSEcCtD
Indomethacin—Tachycardia—Prednisone—Crohn's disease	3.89e-05	0.00115	CcSEcCtD
Indomethacin—Hyperhidrosis—Prednisone—Crohn's disease	3.86e-05	0.00114	CcSEcCtD
Indomethacin—Anorexia—Prednisone—Crohn's disease	3.8e-05	0.00113	CcSEcCtD
Indomethacin—Insomnia—Prednisone—Crohn's disease	3.61e-05	0.00107	CcSEcCtD
Indomethacin—Paraesthesia—Prednisone—Crohn's disease	3.58e-05	0.00106	CcSEcCtD
Indomethacin—Dyspepsia—Prednisone—Crohn's disease	3.51e-05	0.00104	CcSEcCtD
Indomethacin—Decreased appetite—Prednisone—Crohn's disease	3.47e-05	0.00103	CcSEcCtD
Indomethacin—Fatigue—Prednisone—Crohn's disease	3.44e-05	0.00102	CcSEcCtD
Indomethacin—Constipation—Prednisone—Crohn's disease	3.41e-05	0.00101	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisone—Crohn's disease	3.29e-05	0.000973	CcSEcCtD
Indomethacin—Gastrointestinal pain—Prednisone—Crohn's disease	3.26e-05	0.000965	CcSEcCtD
Indomethacin—Urticaria—Prednisone—Crohn's disease	3.17e-05	0.000938	CcSEcCtD
Indomethacin—Body temperature increased—Prednisone—Crohn's disease	3.15e-05	0.000933	CcSEcCtD
Indomethacin—Abdominal pain—Prednisone—Crohn's disease	3.15e-05	0.000933	CcSEcCtD
Indomethacin—ABCB1—lymph node—Crohn's disease	3.13e-05	0.00141	CbGeAlD
Indomethacin—Hypersensitivity—Prednisone—Crohn's disease	2.94e-05	0.00087	CcSEcCtD
Indomethacin—Asthenia—Prednisone—Crohn's disease	2.86e-05	0.000847	CcSEcCtD
Indomethacin—Pruritus—Prednisone—Crohn's disease	2.82e-05	0.000835	CcSEcCtD
Indomethacin—Diarrhoea—Prednisone—Crohn's disease	2.73e-05	0.000808	CcSEcCtD
Indomethacin—Dizziness—Prednisone—Crohn's disease	2.64e-05	0.000781	CcSEcCtD
Indomethacin—Vomiting—Prednisone—Crohn's disease	2.54e-05	0.00075	CcSEcCtD
Indomethacin—Rash—Prednisone—Crohn's disease	2.52e-05	0.000744	CcSEcCtD
Indomethacin—Dermatitis—Prednisone—Crohn's disease	2.51e-05	0.000744	CcSEcCtD
Indomethacin—Headache—Prednisone—Crohn's disease	2.5e-05	0.000739	CcSEcCtD
Indomethacin—Nausea—Prednisone—Crohn's disease	2.37e-05	0.000701	CcSEcCtD
Indomethacin—SLCO1B1—Metabolism—MTMR3—Crohn's disease	8.23e-06	0.000228	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.23e-06	0.000228	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	8.2e-06	0.000227	CbGpPWpGaD
Indomethacin—PPARG—Adipogenesis—IL6—Crohn's disease	8.17e-06	0.000226	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—FADS1—Crohn's disease	8.14e-06	0.000226	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GPX4—Crohn's disease	8.06e-06	0.000223	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GPX4—Crohn's disease	8.06e-06	0.000223	CbGpPWpGaD
Indomethacin—PPARA—Circadian rythm related genes—IL6—Crohn's disease	8.05e-06	0.000223	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—RASGRP1—Crohn's disease	8.04e-06	0.000223	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TYK2—Crohn's disease	8.01e-06	0.000222	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—IL2RA—Crohn's disease	7.95e-06	0.00022	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TNF—Crohn's disease	7.84e-06	0.000217	CbGpPWpGaD
Indomethacin—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	7.82e-06	0.000217	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—IL6—Crohn's disease	7.79e-06	0.000216	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GCKR—Crohn's disease	7.79e-06	0.000216	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GCKR—Crohn's disease	7.79e-06	0.000216	CbGpPWpGaD
Indomethacin—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	7.77e-06	0.000215	CbGpPWpGaD
Indomethacin—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.76e-06	0.000215	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.7e-06	0.000213	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	7.7e-06	0.000213	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—JAK2—Crohn's disease	7.65e-06	0.000212	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GPX4—Crohn's disease	7.63e-06	0.000211	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RBX1—Crohn's disease	7.51e-06	0.000208	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—FADS1—Crohn's disease	7.5e-06	0.000208	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.41e-06	0.000205	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.39e-06	0.000205	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GCKR—Crohn's disease	7.37e-06	0.000204	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.34e-06	0.000204	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MTMR3—Crohn's disease	7.32e-06	0.000203	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTGER4—Crohn's disease	7.31e-06	0.000203	CbGpPWpGaD
Indomethacin—ABCC1—Disease—GCKR—Crohn's disease	7.29e-06	0.000202	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—HSPA1B—Crohn's disease	7.18e-06	0.000199	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RSPO3—Crohn's disease	7.14e-06	0.000198	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.07e-06	0.000196	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GPX4—Crohn's disease	7.02e-06	0.000195	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—FADS1—Crohn's disease	7e-06	0.000194	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—FADS1—Crohn's disease	7e-06	0.000194	CbGpPWpGaD
Indomethacin—PPARA—Transmembrane transport of small molecules—ALB—Crohn's disease	6.98e-06	0.000194	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	6.98e-06	0.000193	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.92e-06	0.000192	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PLA2G4F—Crohn's disease	6.84e-06	0.000189	CbGpPWpGaD
Indomethacin—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	6.81e-06	0.000189	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GCKR—Crohn's disease	6.78e-06	0.000188	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SEL1L—Crohn's disease	6.76e-06	0.000187	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—FADS1—Crohn's disease	6.75e-06	0.000187	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.73e-06	0.000187	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—SMAD3—Crohn's disease	6.73e-06	0.000186	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—UBE2D1—Crohn's disease	6.59e-06	0.000183	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GPX4—Crohn's disease	6.55e-06	0.000182	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GPX4—Crohn's disease	6.55e-06	0.000182	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCR6—Crohn's disease	6.55e-06	0.000182	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SLC11A1—Crohn's disease	6.44e-06	0.000179	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.43e-06	0.000178	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—IL2RA—Crohn's disease	6.42e-06	0.000178	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—FADS1—Crohn's disease	6.41e-06	0.000178	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RIPK2—Crohn's disease	6.39e-06	0.000177	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GCKR—Crohn's disease	6.33e-06	0.000175	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GCKR—Crohn's disease	6.33e-06	0.000175	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—IL6—Crohn's disease	6.32e-06	0.000175	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GPX4—Crohn's disease	6.32e-06	0.000175	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.31e-06	0.000175	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—UBE2D1—Crohn's disease	6.29e-06	0.000174	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—SMAD3—Crohn's disease	6.28e-06	0.000174	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.25e-06	0.000173	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL3—Crohn's disease	6.23e-06	0.000173	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	6.23e-06	0.000173	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TYK2—Crohn's disease	6.22e-06	0.000172	CbGpPWpGaD
Indomethacin—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	6.21e-06	0.000172	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.2e-06	0.000172	CbGpPWpGaD
Indomethacin—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	6.18e-06	0.000171	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GCKR—Crohn's disease	6.1e-06	0.000169	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	6.09e-06	0.000169	CbGpPWpGaD
Indomethacin—PTGS2—Disease—LTF—Crohn's disease	6.07e-06	0.000168	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RASGRP1—Crohn's disease	6.02e-06	0.000167	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GPX4—Crohn's disease	6.01e-06	0.000166	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—TNF—Crohn's disease	5.95e-06	0.000165	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—JAK2—Crohn's disease	5.94e-06	0.000165	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RBX1—Crohn's disease	5.93e-06	0.000164	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—IL6—Crohn's disease	5.89e-06	0.000163	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL2RA—Crohn's disease	5.83e-06	0.000161	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTMR3—Crohn's disease	5.81e-06	0.000161	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GCKR—Crohn's disease	5.8e-06	0.000161	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTGER4—Crohn's disease	5.77e-06	0.00016	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—IL6—Crohn's disease	5.77e-06	0.00016	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—ALB—Crohn's disease	5.75e-06	0.000159	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TYK2—Crohn's disease	5.74e-06	0.000159	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—FADS1—Crohn's disease	5.71e-06	0.000158	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—STAT3—Crohn's disease	5.61e-06	0.000155	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.57e-06	0.000154	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLA2G4F—Crohn's disease	5.53e-06	0.000153	CbGpPWpGaD
Indomethacin—ABCC1—Disease—RBX1—Crohn's disease	5.52e-06	0.000153	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HSPA1B—Crohn's disease	5.52e-06	0.000153	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.48e-06	0.000152	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—JAK2—Crohn's disease	5.48e-06	0.000152	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SOCS1—Crohn's disease	5.46e-06	0.000151	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CXCL8—Crohn's disease	5.42e-06	0.00015	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—JAK2—Crohn's disease	5.34e-06	0.000148	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GPX4—Crohn's disease	5.34e-06	0.000148	CbGpPWpGaD
Indomethacin—ABCC3—Transmembrane transport of small molecules—ALB—Crohn's disease	5.29e-06	0.000147	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—ITGA4—Crohn's disease	5.27e-06	0.000146	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.26e-06	0.000146	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—UBE2D1—Crohn's disease	5.2e-06	0.000144	CbGpPWpGaD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	5.19e-06	0.000144	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GCKR—Crohn's disease	5.16e-06	0.000143	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—ALB—Crohn's disease	5.16e-06	0.000143	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—IL6—Crohn's disease	5.15e-06	0.000143	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL3—Crohn's disease	5.14e-06	0.000142	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RIPK2—Crohn's disease	5.04e-06	0.00014	CbGpPWpGaD
Indomethacin—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	5.02e-06	0.000139	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	4.98e-06	0.000138	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—RASGRP1—Crohn's disease	4.97e-06	0.000138	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	4.97e-06	0.000138	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL3—Crohn's disease	4.91e-06	0.000136	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	4.91e-06	0.000136	CbGpPWpGaD
Indomethacin—PTGS2—Disease—GCKR—Crohn's disease	4.89e-06	0.000136	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.87e-06	0.000135	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—TNF—Crohn's disease	4.86e-06	0.000135	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.85e-06	0.000134	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	4.85e-06	0.000134	CbGpPWpGaD
Indomethacin—ABCC1—Disease—UBE2D1—Crohn's disease	4.84e-06	0.000134	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RASGRP1—Crohn's disease	4.75e-06	0.000132	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SMAD3—Crohn's disease	4.71e-06	0.000131	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTMR3—Crohn's disease	4.7e-06	0.00013	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	4.69e-06	0.00013	CbGpPWpGaD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	4.61e-06	0.000128	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.6e-06	0.000128	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—FADS1—Crohn's disease	4.53e-06	0.000125	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	4.53e-06	0.000125	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.52e-06	0.000125	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PTGS2—Crohn's disease	4.51e-06	0.000125	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—SMAD3—Crohn's disease	4.5e-06	0.000125	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—TYK2—Crohn's disease	4.39e-06	0.000122	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—ALB—Crohn's disease	4.39e-06	0.000122	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2RA—Crohn's disease	4.36e-06	0.000121	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.36e-06	0.000121	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—STAT3—Crohn's disease	4.36e-06	0.000121	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.35e-06	0.00012	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	4.33e-06	0.00012	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SLC11A1—Crohn's disease	4.32e-06	0.00012	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—JAK2—Crohn's disease	4.31e-06	0.000119	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SOCS1—Crohn's disease	4.31e-06	0.000119	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GPX4—Crohn's disease	4.24e-06	0.000118	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.24e-06	0.000117	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTMR3—Crohn's disease	4.22e-06	0.000117	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	4.2e-06	0.000116	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—JAK2—Crohn's disease	4.19e-06	0.000116	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.15e-06	0.000115	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.14e-06	0.000115	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.14e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTMR3—Crohn's disease	4.12e-06	0.000114	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—TYK2—Crohn's disease	4.1e-06	0.000114	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GCKR—Crohn's disease	4.1e-06	0.000113	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—STAT3—Crohn's disease	4.02e-06	0.000111	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CD4—Crohn's disease	3.97e-06	0.00011	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.96e-06	0.00011	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.94e-06	0.000109	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTGS2—Crohn's disease	3.94e-06	0.000109	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—IL6—Crohn's disease	3.92e-06	0.000109	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—JAK2—Crohn's disease	3.92e-06	0.000109	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTMR3—Crohn's disease	3.85e-06	0.000107	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTGS2—Crohn's disease	3.84e-06	0.000106	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.82e-06	0.000106	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ALB—Crohn's disease	3.77e-06	0.000105	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SMAD3—Crohn's disease	3.72e-06	0.000103	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RBX1—Crohn's disease	3.71e-06	0.000103	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HSPA1B—Crohn's disease	3.71e-06	0.000103	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.69e-06	0.000102	CbGpPWpGaD
Indomethacin—ALB—Metabolism—FADS1—Crohn's disease	3.66e-06	0.000102	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.63e-06	0.0001	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2RA—Crohn's disease	3.6e-06	9.97e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—TNF—Crohn's disease	3.48e-06	9.65e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SMAD3—Crohn's disease	3.46e-06	9.6e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2RA—Crohn's disease	3.44e-06	9.54e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX4—Crohn's disease	3.43e-06	9.51e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GCKR—Crohn's disease	3.31e-06	9.18e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—Crohn's disease	3.3e-06	9.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—FADS1—Crohn's disease	3.29e-06	9.11e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ALB—Crohn's disease	3.27e-06	9.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—UBE2D1—Crohn's disease	3.25e-06	9.01e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.23e-06	8.94e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—FADS1—Crohn's disease	3.21e-06	8.9e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX4—Crohn's disease	3.08e-06	8.53e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TYK2—Crohn's disease	3.07e-06	8.52e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—STAT3—Crohn's disease	3.07e-06	8.52e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—Crohn's disease	3.04e-06	8.44e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX4—Crohn's disease	3.01e-06	8.33e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—FADS1—Crohn's disease	3e-06	8.31e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GCKR—Crohn's disease	2.97e-06	8.24e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.93e-06	8.13e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—JAK2—Crohn's disease	2.93e-06	8.13e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.93e-06	8.11e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GCKR—Crohn's disease	2.9e-06	8.05e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—Crohn's disease	2.86e-06	7.93e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—Crohn's disease	2.81e-06	7.78e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX4—Crohn's disease	2.81e-06	7.78e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GCKR—Crohn's disease	2.71e-06	7.52e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCL8—Crohn's disease	2.68e-06	7.42e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ALB—Crohn's disease	2.48e-06	6.87e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ALB—Crohn's disease	2.48e-06	6.87e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TYK2—Crohn's disease	2.42e-06	6.72e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—JAK2—Crohn's disease	2.42e-06	6.7e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ALB—Crohn's disease	2.34e-06	6.5e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SMAD3—Crohn's disease	2.33e-06	6.44e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JAK2—Crohn's disease	2.31e-06	6.41e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TYK2—Crohn's disease	2.26e-06	6.26e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—Crohn's disease	2.17e-06	6.01e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—Crohn's disease	2.17e-06	6.01e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ALB—Crohn's disease	2.16e-06	5.98e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—JAK2—Crohn's disease	2.16e-06	5.97e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—Crohn's disease	2.15e-06	5.96e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—Crohn's disease	2.15e-06	5.95e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.13e-06	5.89e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.07e-06	5.74e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—Crohn's disease	2.05e-06	5.68e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD4—Crohn's disease	2.04e-06	5.66e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—Crohn's disease	2.03e-06	5.62e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—Crohn's disease	2.01e-06	5.58e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—Crohn's disease	2.01e-06	5.58e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—Crohn's disease	2.01e-06	5.56e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.97e-06	5.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—Crohn's disease	1.94e-06	5.38e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.94e-06	5.37e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—Crohn's disease	1.89e-06	5.23e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.86e-06	5.15e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—Crohn's disease	1.85e-06	5.11e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—Crohn's disease	1.76e-06	4.88e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—Crohn's disease	1.76e-06	4.88e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—Crohn's disease	1.7e-06	4.71e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—Crohn's disease	1.7e-06	4.7e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.7e-06	4.7e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—Crohn's disease	1.64e-06	4.55e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—Crohn's disease	1.61e-06	4.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—Crohn's disease	1.58e-06	4.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TYK2—Crohn's disease	1.52e-06	4.2e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—Crohn's disease	1.5e-06	4.17e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—JAK2—Crohn's disease	1.45e-06	4.01e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—Crohn's disease	1.44e-06	3.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—Crohn's disease	1.37e-06	3.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—Crohn's disease	1.3e-06	3.61e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—Crohn's disease	1.19e-06	3.29e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—Crohn's disease	1.11e-06	3.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—Crohn's disease	1.06e-06	2.94e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—Crohn's disease	9.47e-07	2.62e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—Crohn's disease	9.24e-07	2.56e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—Crohn's disease	9.23e-07	2.56e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—Crohn's disease	8.63e-07	2.39e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—Crohn's disease	8.28e-07	2.3e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—Crohn's disease	8.08e-07	2.24e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—Crohn's disease	7.55e-07	2.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—Crohn's disease	7.42e-07	2.06e-05	CbGpPWpGaD
